Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Lupus Nephritis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Circuit Clinical, Orchard Park, New York, United States

    Contact: Study coordinator (Gabriella Demelo) · gdemelo@circuitclinical.com
    Contact: Principal Investigator (Isha Gupta)
  • Novartis Investigative Site, Vitória, Espírito Santo, Brazil

  • Novartis Investigative Site, Salvador, Estado de Bahia, Brazil

  • Novartis Investigative Site, Belo Horizonte, Minas Gerais, Brazil

  • Novartis Investigative Site, Santo André, São Paulo, Brazil

  • Novartis Investigative Site, Guangzhou, Guangdong, China

  • Novartis Investigative Site, Shantou, Guangdong, China

  • Novartis Investigative Site, Shenzhen, Guangdong, China

  • Novartis Investigative Site, Liuzhou, Guangxi, China

  • Novartis Investigative Site, Wuhan, Hubei, China

  • Novartis Investigative Site, Changchun, Jilin, China

  • Novartis Investigative Site, Binzhou, Shandong, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Chongqing, China

  • Novartis Investigative Site, Guangzhou, China

  • Novartis Investigative Site, Guangzhou, China

  • Novartis Investigative Site, Shanghai, China

  • Novartis Investigative Site, Barranquilla, Atlántico, Colombia

  • Novartis Investigative Site, Olomouc, Czechia

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Guatemala City, Guatemala

  • Novartis Investigative Site, Guatemala City, Guatemala

  • Novartis Investigative Site, Tuenmen, Hong Kong

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Kuala Lumpur, Kuala Lumpur, Malaysia

  • Novartis Investigative Site, Sibu, Sarawak, Malaysia

  • Novartis Investigative Site, León, Guanajuato, Mexico

  • Novartis Investigative Site, Oaxaca City, Mexico

  • Novartis Investigative Site, Querétaro, Mexico

  • Novartis Investigative Site, Bucharest, Romania

  • Novartis Investigative Site, Singapore, Singapore

  • Novartis Investigative Site, Singapore, Singapore

  • Novartis Investigative Site, Suwon, Gyeonggi-do, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Barcelona, Spain

  • Novartis Investigative Site, Taichung, Taiwan

  • Novartis Investigative Site, Songkhla, Hat Yai, Thailand

  • Novartis Investigative Site, Bangkok, Thailand

  • Novartis Investigative Site, Bangkok, Thailand

  • Novartis Investigative Site, Chiang Mai, Thailand

מובילי המחקר
  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals